Grace Chen is an experienced Quality Control Specialist with a solid background in microbiology. Currently serving as a QC Specialist IV at CTMC, a joint venture involving Resilience and MD Anderson Cancer Center since June 2022, Grace has previously held key roles at Alaunos Therapeutics as a Sr. QC Microbiologist Analyst and MD Anderson Cancer Center as a Biologics QC Specialist III. Additional experience includes positions as Microbiologist III and Environmental Monitoring Specialist at Bellicum Pharmaceuticals, Microbiology Manager and Microbiologist at WDPrx - Woodfield Pharmaceutical, and Microbiology Laboratory Technician at Biotics Research Inc. Grace holds a Bachelor of Science degree in Microbiology from The University of Texas at Austin, obtained in 2007.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200